Mineralys Therapeutics, Inc. ($MLYS)
Filing Information
| Accession Number | 0001933414-26-000007 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 11, 2026 |
| Document Date | Feb 9, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
6,513
Total Value
$100,321.91
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Stock | โ | Feb 9, 2026 | Exercise/Conversion | 2,171 | $16.00 | $34,736.00 | 52,608 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Feb 9, 2026 | Sale | 2,171 | $30.21 | $65,585.91 | 50,437 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option | Derivative | Feb 9, 2026 | Exercise/Conversion | 2,171 | $0.00 | $0.00 | 26,047 | Direct | โ | View Details |